Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of adenosine A3 receptor antagonists to inhibit tumor growth

Use of adenosine A3 receptor antagonists to inhibit tumor growth

US Patent 6326390 · Granted Dec 4, 2001

Estimated economic value: $110,261,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-cancer compounds2016
Biarylcarboxyarylamides as vanilloid-1 receptor modulators2012
Biarylcarboxyarylamides as vanilloid-1 receptor modulators2012
Vanilloid TRPV1 receptor antagonists2011
Vanilloid TRPV1 receptor antagonists2011
VR1 vanilloid receptor antagonists with a iononic substructure2011
VR1 vanilloid receptor antagonists with a iononic substructure2011
Allosteric modulators of the A1 adenosine receptor2011
Allosteric modulators of the A1 adenosine receptor2010
Adenosine A2B receptor antagonists2010
Adenosine A2B receptor antagonists2010
O-substituted-dibenzyl urea-derivatives as TRPV1 receptor antagonists2010